• 
• 
• 
• 
• 

2017

• Furukawa A, Kakita K, Yamada T, Ishizuka M, Sakamoto J, Hatori N, Maeda N, Ohsaka F, Saitoh T, Nomura T, Kuroki K, Nambu H, Arase H, Matsunaga S, Anada M, Ose T, Hashimoto S, Maenaka K.
  Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILRα immune cell receptor.
  J Biol Chem. 2017 Dec 22;292(51):21128-21136. doi: 10.1074/jbc.M117.799239. Epub 2017 Oct 18.
• Abe Y, Shioi S, Kita S, Nakata H, Maenaka K, Kohda D, Katayama T, Ueda T.
  X-ray crystal structure of Escherichia coli HspQ, a protein involved in the retardation of replication initiation.
  FEBS Lett. 2017 Nov;591(22):3805-3816. doi: 10.1002/1873-3468.12892. Epub 2017 Nov 12.
• Maeda N, Maenaka K.
  The Roles of Matricellular Proteins in Oncogenic Virus-Induced Cancers and Their Potential Utilities as Therapeutic Targets.
  Int J Mol Sci. 2017 Oct 21;18(10). pii: E2198. doi: 10.3390/ijms18102198.
• Fukuda N, Noi K, Weng L, Kobashigawa Y, Miyazaki H, Wakeyama Y, Takaki M, Nakahara Y, Tatsuno Y, Uchida-Kamekura M, Suwa Y, Sato T, Ichikawa-Tomikawa N, Nomizu M, Fujiwara Y, Ohsaka F, Saitoh T, Maenaka K, Kumeta H, Shinya S, Kojima C, Ogura T, Morioka H.
  Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion.
  Molecules. 2017 Oct 10;22(10). pii: E1695. doi: 10.3390/molecules22101695.
• Maeda N, Yamada C, Takahashi A, Kuroki K, Maenaka K.
  Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice.
  Int Immunopharmacol. 2017 Sep;50:202-207. doi: 10.1016/j.intimp.2017.06.026. Epub 2017 Jul 1.
• Ban T, Ishihara T, Kohno H, Saita S, Ichimura A, Maenaka K, Oka T, Mihara K, Ishihara N.
  Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin.
  Nat Cell Biol. 2017 Jul;19(7):856-863. doi: 10.1038/ncb3560. Epub 2017 Jun 19.
• Matsumaru T, Inai M, Ishigami K, Iwamatsu T, Maita H, Otsuguro S, Nomura T, Matsuda A, Ichikawa S, Sakaitani M, Shuto S, Maenaka K, Kan T.
  Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors.
  Bioorg Med Chem Lett. 2017 May 15;27(10):2144-2147. doi: 10.1016/j.bmcl.2017.03.055. Epub 2017 Mar 23.
• Kuroki K, Mio K, Takahashi A, Matsubara H, Kasai Y, Manaka S, Kikkawa M, Hamada D, Sato C, Maenaka K.
  Cutting Edge: Class II-like Structural Features and Strong Receptor Binding of the Nonclassical HLA-G2 Isoform Homodimer.
  J Immunol. 2017 May 1;198(9):3399-3403. doi: 10.4049/jimmunol.1601296. Epub 2017 Mar 27.
• Inoue M, Ando D, Kamada H, Taki S, Niiyama M, Mukai Y, Tadokoro T, Maenaka K, Nakayama T, Kado Y, Inoue T, Tsutsumi Y, Tsunoda SI.
  A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification.
  J Biol Chem. 2017 Apr 21;292(16):6438-6451. doi: 10.1074/jbc.M117.779686. Epub 2017 Feb 24.

• 
•